< Back to scientific publications

Magazine 10,298

The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly

Authors: Corsonello A, Abbatecola AM, Fusco S, Luciani F, Marino A, Catalano S, Maggio MG, Lattanzio F

Date: 2015

Scope of interest: infection




You may also be interested in:

Magazine 4.26

The grey zone between autoimmune encephalitis and autoimmune-associated epilepsy

Authors: Morano A, Cerulli Irelli E, Fanella M, Zuliani L, Giallonardo AT, Di Bonaventura C.

Date: 2021

Scope of interest: Epilepsy/autoimmune diseases of the CNS


Read details
Report/Poster of Convention/Congress Act

Analysis of the costs of RHD genotyping and anti-D immunoprophylaxis in D-variant women with pregnancy potential.

Authors: Matteocci A., et. al., D’Amico C. et al.

Date: 2020

Scope of interest: Transfusion Medicine


Read details
Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy


Read details